The pivaloyl chloride market is projected to grow from USD 157.2 million in 2025 to USD 252.0 million by 2035, at a CAGR of 4.8%. Pharmaceutical Intermediates will dominate with a 43.6% market share, while pharmaceuticals will lead the end-use industry segment with a 47.2% share.